Overview

Venetoclax Combined with Intensive Therapy for Acute Myeloid Leukemia Patients with Lower Early Peripheral Blast Clearance Rate After Standard Induction Therapy

Status:
RECRUITING
Trial end date:
2027-10-31
Target enrollment:
Participant gender:
Summary
This single-center prospective cohort study aims to evaluate the efficacy and safety of Intensifying treatment with Venetoclax along with intensive chemotherapy in patients with newly diagnosed acute myeloid leukemia (AML) except acute promyelocytic leukemia (non-APL) and exhibiting lower early peripheral blast clearance rate (EPBCR) after standard Intensive Induction therapy (3+7 regimen).
Phase:
NA
Details
Lead Sponsor:
Affiliated Hospital of Nantong University
Treatments:
Cytarabine
venetoclax